AI-generated summary
The authors studied 278 pre-myopic children randomly assigned to repeated low-level red-light therapy or a control group for one year. They report that choroidal thickness increased at the 3-month visit in treated children, and that the 3-month change in choroidal thickness, combined with baseline factors, showed acceptable predictive value for myopia prevention. Treatment was interrupted for many participants during the COVID-19 pandemic.
- Participants
- 278
- Who or what was studied
- Pre-myopic children (spherical equivalent refraction between -0.50 D and +0.50 D), randomly assigned to repeated low-level red-light therapy or control; 463 eyes analyzed.
- Limits stated in the abstract
- Treatment was interrupted for 176 participants in the red-light group due to the COVID-19 pandemic, and the abstract reports predictive associations rather than causal effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.